- Home
- PSO vs BAX Comparison
PSO vs BAX Comparison
Compare PSO & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSO
- BAX
- Stock Information
- Founded
- PSO 1844
- BAX 1931
- Country
- PSO United Kingdom
- BAX United States
- Employees
- PSO N/A
- BAX N/A
- Industry
- PSO Books
- BAX Medical/Dental Instruments
- Sector
- PSO Consumer Discretionary
- BAX Health Care
- Exchange
- PSO Nasdaq
- BAX Nasdaq
- Market Cap
- PSO 9.5B
- BAX 11.3B
- IPO Year
- PSO 2000
- BAX N/A
- Fundamental
- Price
- PSO $13.13
- BAX $17.87
- Analyst Decision
- PSO
- BAX Hold
- Analyst Count
- PSO 0
- BAX 10
- Target Price
- PSO N/A
- BAX $27.00
- AVG Volume (30 Days)
- PSO 747.8K
- BAX 7.6M
- Earning Date
- PSO 01-01-0001
- BAX 10-30-2025
- Dividend Yield
- PSO 2.48%
- BAX 3.79%
- EPS Growth
- PSO 31.65
- BAX N/A
- EPS
- PSO 0.90
- BAX N/A
- Revenue
- PSO $4,822,578,436.00
- BAX $11,023,000,000.00
- Revenue This Year
- PSO $2.17
- BAX $5.72
- Revenue Next Year
- PSO $5.10
- BAX $2.52
- P/E Ratio
- PSO $14.67
- BAX N/A
- Revenue Growth
- PSO N/A
- BAX 3.90
- 52 Week Low
- PSO $13.07
- BAX $17.47
- 52 Week High
- PSO $17.90
- BAX $37.74
- Technical
- Relative Strength Index (RSI)
- PSO 26.69
- BAX 19.23
- Support Level
- PSO $13.63
- BAX $17.47
- Resistance Level
- PSO $13.82
- BAX $23.35
- Average True Range (ATR)
- PSO 0.16
- BAX 0.57
- MACD
- PSO -0.16
- BAX -0.50
- Stochastic Oscillator
- PSO 2.76
- BAX 6.52
About PSO Pearson Plc
Pearson PLC listed in the U.K., is an educational provider. The company has been divesting non-core businesses such as the Financial Times, The Economist, and publishing house Penguin, and is now focused on being an educational resource and testing provider. While Pearson's primary activity centers on higher education, the firm also operates in providing clinical assessments, professional certification, and testing.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.